Viela Bio
Viela Bio is a Biotechnology company. It is dedicated to the development and commercialization of novel, life changing medicines for patients with a wide range of autoimmune and severe inflammatory diseases. The headquarters is in USA.
Horizon Therapeutics acquired Viela Bio in 2021 for 3 billion USD.
As on Sep 2020, they have 166 employees.